Preferred binding of gain-of-function mutant p53 to bidirectional promoters with coordinated binding of ETS1 and gabpa to multiple binding sites

Oncotarget

Volumn 5, Issue 2, 2014, Pages 417-427

  Vaughan, Catherine A ^a   Deb, Swati P ^a,c   Deb, Sumitra ^a,c   Windle, Brad ^a,b,c  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

Bi directional promoter; ChIP Seq; ETS1; Mutant p53

Indexed keywords

BINDING PROTEIN; ETS1 PROTEIN; GA BINDING PROTEIN; PROTEIN P53; UNCLASSIFIED DRUG; DNA; ETS1 PROTEIN, HUMAN; GABPA PROTEIN, HUMAN; TP53 PROTEIN, HUMAN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR ETS 1;

ARTICLE; BINDING SITE; CHROMATIN IMMUNOPRECIPITATION; COMPLEX FORMATION; CONTROLLED STUDY; DNA HELIX; DNA SEQUENCE; GAIN OF FUNCTION MUTATION; GENE EXPRESSION; GENE INTERACTION; GENE MAPPING; HUMAN; HUMAN CELL; PROMOTER REGION; PROTEIN BINDING; PROTEIN MOTIF; SEQUENCE ANALYSIS; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR GENE; GENETICS; LUNG TUMOR; METABOLISM; TUMOR CELL LINE;

BINDING SITES; CELL LINE, TUMOR; DNA, NEOPLASM; GA-BINDING PROTEIN TRANSCRIPTION FACTOR; GENE EXPRESSION; HUMANS; LUNG NEOPLASMS; PROMOTER REGIONS, GENETIC; PROTO-ONCOGENE PROTEIN C-ETS-1; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84896709078     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.1708     Document Type: Article

References (35)

1. Muller, P.A. and Vousden, K.H. p53 mutations in cancer. Nat Cell Biol. 2013; 15(1): 2-8.
2. Oren, M. and Rotter, V. Mutant p53 gain-of-function in cancer. Cold Spring Harb Perspect Biol. 2010; 2(2): a001107.
3. Beckerman, R. and Prives, C. Transcriptional regulation by p53. Cold Spring Harb Perspect Biol. 2010; 2(8): a000935.
4. Goh, A.M., Coffill, C.R., and Lane, D.P. The role of mutant p53 in human cancer. J Pathol. 2011; 223(2): 116-126.
5. Vousden, K.H. and Prives, C. Blinded by the Light: The Growing Complexity of p53. Cell. 2009; 137(3): 413-431.
6. Scian, M.J., Stagliano, K.E., Anderson, M.A., Hassan, S., Bowman, M., Miles, M.F., Deb, S.P., and Deb, S. Tumorderived p53 mutants induce NF-kappaB2 gene expression. Mol Cell Biol. 2005; 25(22): 10097-10110.
7. Sigal, A. and Rotter, V. Oncogenic mutations of the p53 tumor suppressor: the demons of the guardian of the genome. Cancer Res. 2000; 60(24): 6788-6793.
8. Weisz, L., Damalas, A., Liontos, M., Karakaidos, P., Fontemaggi, G., Maor-Aloni, R., Kalis, M., Levrero, M., Strano, S., Gorgoulis, V.G., Rotter, V., Blandino, G., and Oren, M. Mutant p53 enhances nuclear factor kappaB activation by tumor necrosis factor alpha in cancer cells. Cancer Res. 2007; 67(6): 2396-2401.
9. Gaiddon, C., Lokshin, M., Ahn, J., Zhang, T., and Prives, C. A subset of tumor-derived mutant forms of p53 downregulate p63 and p73 through a direct interaction with the p53 core domain. Mol Cell Biol. 2001; 21(5): 1874-1887.
10. Freed-Pastor, W.A. and Prives, C. Mutant p53: one name, many proteins. Genes Dev. 2012; 26(12): 1268-1286.
11. Hwang, C.I., Matoso, A., Corney, D.C., Flesken-Nikitin, A., Korner, S., Wang, W., Boccaccio, C., Thorgeirsson, S.S., Comoglio, P.M., Hermeking, H., and Nikitin, A.Y. Wild-type p53 controls cell motility and invasion by dual regulation of MET expression. Proc Natl Acad Sci U S A. 2011; 108(34): 14240-14245.
12. Do, P.M., Varanasi, L., Fan, S., Li, C., Kubacka, I., Newman, V., Chauhan, K., Daniels, S.R., Boccetta, M., Garrett, M.R., Li, R., and Martinez, L.A. Mutant p53 cooperates with ETS2 to promote etoposide resistance. Genes Dev. 2012; 26(8): 830-845.
13. Sampath, J., Sun, D., Kidd, V.J., Grenet, J., Gandhi, A., Shapiro, L.H., Wang, Q., Zambetti, G.P., and Schuetz, J.D. Mutant p53 cooperates with ETS and selectively upregulates human MDR1 not MRP1. J Biol Chem. 2001; 276(42): 39359-39367.
14. Di Agostino, S., Strano, S., Emiliozzi, V., Zerbini, V., Mottolese, M., Sacchi, A., Blandino, G., and Piaggio, G. Gain of function of mutant p53: the mutant p53/ NF-Y protein complex reveals an aberrant transcriptional mechanism of cell cycle regulation. Cancer Cell. 2006; 10(3): 191-202.
15. Stambolsky, P., Tabach, Y., Fontemaggi, G., Weisz, L., Maor-Aloni, R., Siegfried, Z., Shiff, I., Kogan, I., Shay, M., Kalo, E., Blandino, G., Simon, I., Oren, M., et al. Modulation of the vitamin D3 response by cancerassociated mutant p53. Cancer Cell. 2010; 17(3): 273-285.
16. Borellini, F. and Glazer, R.I. Induction of Sp1-p53 DNAbinding heterocomplexes during granulocyte/macrophage colony-stimulating factor-dependent proliferation in human erythroleukemia cell line TF-1. J Biol Chem. 1993; 268(11): 7923-7928.
17. Gualberto, A., Aldape, K., Kozakiewicz, K., and Tlsty, T.D. An oncogenic form of p53 confers a dominant, gain-offunction phenotype that disrupts spindle checkpoint control. Proc Natl Acad Sci U S A. 1998; 95(9): 5166-5171.
18. Dell'Orso, S., Fontemaggi, G., Stambolsky, P., Goeman, F., Voellenkle, C., Levrero, M., Strano, S., Rotter, V., Oren, M., and Blandino, G. ChIP-on-chip analysis of in vivo mutant p53 binding to selected gene promoters. Omics. 2011; 15(5): 305-312.
19. Garritano, S., Inga, A., Gemignani, F., and Landi, S. More targets, more pathways and more clues for mutant p53. Oncogenesis. 2013; 2: e54.
20. Martynova, E., Pozzi, S., Basile, V., Dolfini, D., Zambelli, F., Imbriano, C., Pavesi, G., and Mantovani, R. Gain-offunction p53 mutants have widespread genomic locations partially overlapping with p63. Oncotarget. 2012; 3(2): 132-143.
21. Weisz, L., Zalcenstein, A., Stambolsky, P., Cohen, Y., Goldfinger, N., Oren, M., and Rotter, V. Transactivation of the EGR1 gene contributes to mutant p53 gain of function. Cancer Res. 2004; 64(22): 8318-8327.
22. Trinklein, N.D., Aldred, S.F., Hartman, S.J., Schroeder, D.I., Otillar, R.P., and Myers, R.M. An abundance of bidirectional promoters in the human genome. Genome Res. 2004; 14(1): 62-66.
23. Wei, W., Pelechano, V., Jarvelin, A.I., and Steinmetz, L.M. Functional consequences of bidirectional promoters. Trends Genet. 2011; 27(7): 267-276.
24. Yang, M.Q., Koehly, L.M., and Elnitski, L.L. Comprehensive annotation of bidirectional promoters identifies co-regulation among breast and ovarian cancer genes. PLoS Comput Biol. 2007; 3(4): e72.
25. Collins, P.J., Kobayashi, Y., Nguyen, L., Trinklein, N.D., and Myers, R.M. The ets-related transcription factor GABP directs bidirectional transcription. PLoS Genet. 2007; 3(11): e208.
26. Babayeva, N.D., Wilder, P.J., Shiina, M., Mino, K., Desler, M., Ogata, K., Rizzino, A., and Tahirov, T.H. Structural basis of Ets1 cooperative binding to palindromic sequences on stromelysin-1 promoter DNA. Cell Cycle. 2010; 9(15): 3054-3062.
27. Baillat, D., Begue, A., Stehelin, D., and Aumercier, M. ETS-1 transcription factor binds cooperatively to the palindromic head to head ETS-binding sites of the stromelysin-1 promoter by counteracting autoinhibition. J Biol Chem. 2002; 277(33): 29386-29398.
28. Kornberg, R.D. and Lorch, Y. Twenty-five years of the nucleosome, fundamental particle of the eukaryote chromosome. Cell. 1999; 98(3): 285-294.
29. Babayeva, N.D., Baranovskaya, O.I., and Tahirov, T.H. Structural basis of Ets1 cooperative binding to widely separated sites on promoter DNA. PLoS One. 2012; 7(3): e33698.
30. Scian, M.J., Stagliano, K.E., Deb, D., Ellis, M.A., Carchman, E.H., Das, A., Valerie, K., Deb, S.P., and Deb, S. Tumor-derived p53 mutants induce oncogenesis by transactivating growth-promoting genes. Oncogene. 2004; 23(25): 4430-4443.
31. Meyer, L.R., Zweig, A.S., Hinrichs, A.S., Karolchik, D., Kuhn, R.M., Wong, M., Sloan, C.A., Rosenbloom, K.R., Roe, G., Rhead, B., Raney, B.J., Pohl, A., Malladi, V.S., et al. The UCSC Genome Browser database: extensions and updates 2013. Nucleic Acids Res. 2013; 41(Database issue): D64-69.
32. Vaughan, C.A., Singh, S., Windle, B., Yeudall, W.A., Frum, R., Grossman, S.R., Deb, S.P., and Deb, S. Gain-of-Function Activity of Mutant p53 in Lung Cancer through Up-Regulation of Receptor Protein Tyrosine Kinase Axl. Genes Cancer. 2012; 3(7-8): 491-502.
33. Bailey, T.L., Boden, M., Buske, F.A., Frith, M., Grant, C.E., Clementi, L., Ren, J., Li, W.W., and Noble, W.S. MEME SUITE: tools for motif discovery and searching. Nucleic Acids Res. 2009; 37(Web Server issue): W202-208.
34. Gupta, S., Stamatoyannopoulos, J.A., Bailey, T.L., and Noble, W.S. Quantifying similarity between motifs. Genome Biol. 2007; 8(2): R24.
35. Crooks, G.E., Hon, G., Chandonia, J.M., and Brenner, S.E. WebLogo: a sequence logo generator. Genome Res. 2004; 14(6): 1188-1190